253 related articles for article (PubMed ID: 16877971)
1. Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis.
Gao XM; Wong G; Wang B; Kiriazis H; Moore XL; Su YD; Dart A; Du XJ
J Hypertens; 2006 Aug; 24(8):1663-70. PubMed ID: 16877971
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.
McMullen JR; Sherwood MC; Tarnavski O; Zhang L; Dorfman AL; Shioi T; Izumo S
Circulation; 2004 Jun; 109(24):3050-5. PubMed ID: 15184287
[TBL] [Abstract][Full Text] [Related]
3. Activation or inactivation of cardiac Akt/mTOR signaling diverges physiological from pathological hypertrophy.
Kemi OJ; Ceci M; Wisloff U; Grimaldi S; Gallo P; Smith GL; Condorelli G; Ellingsen O
J Cell Physiol; 2008 Feb; 214(2):316-21. PubMed ID: 17941081
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
[TBL] [Abstract][Full Text] [Related]
5. K(ATP) activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function.
Gao S; Long CL; Wang RH; Wang H
Cardiovasc Res; 2009 Aug; 83(3):444-56. PubMed ID: 19304734
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Jak2 phosphorylation attenuates pressure overload cardiac hypertrophy.
Beckles DL; Mascareno E; Siddiqui MA
Vascul Pharmacol; 2006 Dec; 45(6):350-7. PubMed ID: 16822720
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload.
Grieve DJ; Byrne JA; Siva A; Layland J; Johar S; Cave AC; Shah AM
J Am Coll Cardiol; 2006 Feb; 47(4):817-26. PubMed ID: 16487851
[TBL] [Abstract][Full Text] [Related]
8. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo.
Boluyt MO; Li ZB; Loyd AM; Scalia AF; Cirrincione GM; Jackson RR
Cardiovasc Drugs Ther; 2004 Jul; 18(4):257-67. PubMed ID: 15367823
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term heart rate reduction by If current inhibition on pressure overload-induced heart failure in rats.
Ciobotaru V; Heimburger M; Louedec L; Heymes C; Ventura-Clapier R; Bedossa P; Escoubet B; Michel JB; Mercadier JJ; Logeart D
J Pharmacol Exp Ther; 2008 Jan; 324(1):43-9. PubMed ID: 17901295
[TBL] [Abstract][Full Text] [Related]
10. Parthenolide inhibits STAT3 signaling and attenuates angiotensin II-induced left ventricular hypertrophy via modulation of fibroblast activity.
Skoumal R; Tóth M; Serpi R; Rysä J; Leskinen H; Ulvila J; Saiho T; Aro J; Ruskoaho H; Szokodi I; Kerkelä R
J Mol Cell Cardiol; 2011 Apr; 50(4):634-41. PubMed ID: 21223972
[TBL] [Abstract][Full Text] [Related]
11. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
[TBL] [Abstract][Full Text] [Related]
12. The mTOR signaling pathway mediates control of ribosomal protein mRNA translation in rat liver.
Reiter AK; Anthony TG; Anthony JC; Jefferson LS; Kimball SR
Int J Biochem Cell Biol; 2004 Nov; 36(11):2169-79. PubMed ID: 15313464
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone attenuates myocardial fibrosis in rats with chronic pressure overload-induced left ventricular hypertrophy.
Moreira VO; Pereira CA; Silva MO; Felisbino SL; Cicogna AC; Okoshi K; Aragon FF; Padovani CR; Okoshi MP; Castro AV
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):325-30. PubMed ID: 19278522
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
[TBL] [Abstract][Full Text] [Related]
15. Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction.
Du XJ; Fang L; Gao XM; Kiriazis H; Feng X; Hotchkin E; Finch AM; Chaulet H; Graham RM
J Mol Cell Cardiol; 2004 Nov; 37(5):979-87. PubMed ID: 15522275
[TBL] [Abstract][Full Text] [Related]
16. Raptor-rictor axis in TGFbeta-induced protein synthesis.
Das F; Ghosh-Choudhury N; Mahimainathan L; Venkatesan B; Feliers D; Riley DJ; Kasinath BS; Choudhury GG
Cell Signal; 2008 Feb; 20(2):409-23. PubMed ID: 18068336
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor beta protects the murine heart against left ventricular hypertrophy.
Babiker FA; Lips D; Meyer R; Delvaux E; Zandberg P; Janssen B; van Eys G; Grohé C; Doevendans PA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1524-30. PubMed ID: 16627800
[TBL] [Abstract][Full Text] [Related]
18. Pressure overload induces greater hypertrophy and mortality in female mice with p38alpha MAPK inhibition.
Liu J; Sadoshima J; Zhai P; Hong C; Yang G; Chen W; Yan L; Wang Y; Vatner SF; Vatner DE
J Mol Cell Cardiol; 2006 Oct; 41(4):680-8. PubMed ID: 16928383
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cardiac remodeling by pravastatin is associated with amelioration of endoplasmic reticulum stress.
Zhao H; Liao Y; Minamino T; Asano Y; Asakura M; Kim J; Asanuma H; Takashima S; Hori M; Kitakaze M
Hypertens Res; 2008 Oct; 31(10):1977-87. PubMed ID: 19015605
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
